136 related articles for article (PubMed ID: 38265645)
1. Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance.
Robinson JC; Whaley C; Dhruva SS
N Engl J Med; 2024 Jan; 390(4):338-345. PubMed ID: 38265645
[TBL] [Abstract][Full Text] [Related]
2. Estimated Changes in Manufacturer and Health Care Organization Revenue Following List Price Reductions for Hepatitis C Treatments.
Dickson S; Reynolds I
JAMA Netw Open; 2019 Jul; 2(7):e196541. PubMed ID: 31276176
[TBL] [Abstract][Full Text] [Related]
3. Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance.
Xiao R; Ross JS; Gross CP; Dusetzina SB; McWilliams JM; Sethi RKV; Rathi VK
JAMA Intern Med; 2022 Jun; 182(6):603-611. PubMed ID: 35435948
[TBL] [Abstract][Full Text] [Related]
4. Differences in Cancer Care Expenditures and Utilization for Surgery by Hospital Type Among Patients With Private Insurance.
Takvorian SU; Yasaitis L; Liu M; Lee DJ; Werner RM; Bekelman JE
JAMA Netw Open; 2021 Aug; 4(8):e2119764. PubMed ID: 34342648
[TBL] [Abstract][Full Text] [Related]
5. Association of Financial Integration Between Physicians and Hospitals With Commercial Health Care Prices.
Neprash HT; Chernew ME; Hicks AL; Gibson T; McWilliams JM
JAMA Intern Med; 2015 Dec; 175(12):1932-9. PubMed ID: 26501217
[TBL] [Abstract][Full Text] [Related]
6. Consequences of the 340B Drug Pricing Program.
Desai S; McWilliams JM
N Engl J Med; 2018 Feb; 378(6):539-548. PubMed ID: 29365282
[TBL] [Abstract][Full Text] [Related]
7. Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
Yang EJ; Galan E; Thombley R; Lin A; Seo J; Tseng CW; Resneck JS; Bach PB; Dudley RA
JAMA Netw Open; 2020 Dec; 3(12):e2028510. PubMed ID: 33295971
[TBL] [Abstract][Full Text] [Related]
8. Increasing Divergence in Drug Prices Between the United States and Germany After Implementation of Comparative Effectiveness Analysis and Collective Price Negotiations.
Berkemeier F; Whaley C; Robinson JC
J Manag Care Spec Pharm; 2019 Dec; 25(12):1310-1317. PubMed ID: 31778624
[TBL] [Abstract][Full Text] [Related]
9. Association of Beneficiary-Level Risk Factors and Hospital-Level Characteristics With Medicare Part B Drug Spending Differences Between 340B and Non-340B Hospitals.
Li Y; Xu S
JAMA Netw Open; 2022 Feb; 5(2):e220045. PubMed ID: 35179584
[TBL] [Abstract][Full Text] [Related]
10. Market share and the illusion of power. Can Blue Cross force hospitals to discount?
Staten M; Dunkelberg W; Umbeck J
J Health Econ; 1987 Mar; 6(1):43-58. PubMed ID: 10282729
[TBL] [Abstract][Full Text] [Related]
11. Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.
Conti RM; Nikpay SS; Buntin MB
JAMA Netw Open; 2019 Oct; 2(10):e1914141. PubMed ID: 31664442
[TBL] [Abstract][Full Text] [Related]
12. Physician practice competition and prices paid by private insurers for office visits.
Baker LC; Bundorf MK; Royalty AB; Levin Z
JAMA; 2014 Oct 22-29; 312(16):1653-62. PubMed ID: 25335147
[TBL] [Abstract][Full Text] [Related]
13. Association Between the Percentage of US Drug Sales Subject to Inflation Penalties and the Extent of Drug Price Increases.
Dickson S
JAMA Netw Open; 2020 Sep; 3(9):e2016388. PubMed ID: 32915237
[TBL] [Abstract][Full Text] [Related]
14. Specialty Drug Price Trends in the Federal 340B Drug Discount Program.
Lee CH; Chang J; McCombs J
J Manag Care Spec Pharm; 2019 Feb; 25(2):178-187. PubMed ID: 30698090
[TBL] [Abstract][Full Text] [Related]
15. Total expenditures per patient in hospital-owned and physician-owned physician organizations in California.
Robinson JC; Miller K
JAMA; 2014 Oct 22-29; 312(16):1663-9. PubMed ID: 25335148
[TBL] [Abstract][Full Text] [Related]
16. Roles of prices, poverty, and health in Medicare and private spending in Texas.
White C; Taychakhoonavudh S; Parikh R; Franzini L
Am J Manag Care; 2015 May; 21(5):e303-11. PubMed ID: 26167778
[TBL] [Abstract][Full Text] [Related]
17. Annual Spending per Patient and Quality in Hospital-Owned Versus Physician-Owned Organizations: an Observational Study.
Ho V; Metcalfe L; Vu L; Short M; Morrow R
J Gen Intern Med; 2020 Mar; 35(3):649-655. PubMed ID: 31482340
[TBL] [Abstract][Full Text] [Related]
18. Physician participation in health insurance plans: evidence on Blue Shield.
Sloan FA; Steinwald B
J Hum Resour; 1978; 13(2):237-63. PubMed ID: 670695
[TBL] [Abstract][Full Text] [Related]
19. 340B program presents opportunities--and challenges.
Keough CL; Webster SA
Healthc Financ Manage; 2009 Nov; 63(11):42-4, 46, 48. PubMed ID: 19891397
[TBL] [Abstract][Full Text] [Related]
20. Hospital Prices Grew Substantially Faster Than Physician Prices For Hospital-Based Care In 2007-14.
Cooper Z; Craig S; Gaynor M; Harish NJ; Krumholz HM; Van Reenen J
Health Aff (Millwood); 2019 Feb; 38(2):184-189. PubMed ID: 30715987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
